TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL

EMBO Journal

Volumn 16, Issue 17, 1997, Pages 5386-5397

  Walczak, Henning ^a   Degli Esposti, Mariapia A ^a   Johnson, Richard S ^a   Smolak, Pam J ^a   Waugh, Jennifer Y ^a   Boiani, Norman ^a   Timour, Martin S ^a   Gerhart, Mary J ^a   Schooley, Kenneth A ^a   Smith, Craig A ^a   Goodwin, Raymond G ^a   Rauch, Charles T ^a  

^a AMGEN INC   (United States)

Author keywords

Apoptosis; Caspases; FADD; TNF receptor family; TRAIL

Indexed keywords

CYSTEINE; CYTOKINE; CYTOKINE RECEPTOR; HYBRID PROTEIN; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL LINE; CELL SURFACE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; CYSTEINE ENDOPEPTIDASES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, AMINO ACID; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030880548     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.17.5386     Document Type: Article

References (64)

1. Alderson, M.R. et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med., 181, 71-77.
2. Ameisen, J.C., Estaquier, J. and Idziorek, T. (1994) From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol. Rev., 142, 9-51.
3. Badley, A.D., McElhinny, J.A., Leibson, P.J., Lynch, D.H., Alderson, M.R. and Paya, C.V. (1996) Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol., 70, 199-206.
4. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med., 185, 55-64.
5. Bäumler, C.B., Böhler, T., Herr, I., Benner, A., Krammer, P.H. and Debatin, K.M. (1996) Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood, 88, 1741-1746.
6. Bellarau, D., Gold, D., Selawry, H., Moore, J., Feanzusoff, A. and Duke, R.C. (1995) A role for CD95 ligand in preventing graft rejection. Nature, 377, 630-632.
7. Biemann, K. (1990) Appendix 5. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol., 193, 886-887.
8. Bodmer, J. et al. (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity, 6, 79-88.
9. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell, 85, 803-815.
10. Brojatsch, J., Naughton, J., Rolls, M.M., Zingler, K. and Young, J.A.T. (1996) CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell, 87, 845-855.
11. Brunner, T. et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature, 373, 441-444.
12. Cerami, A. and Beutler, B. (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today, 9, 28-31.
13. Chervonsky, A.V., Wang, Y., Wong, F.S., Visitin, I., Flavell, R.A., Janeway, C. A., Jr and Matis, L.A. (1997) The role of Fas in autoimmune diabetes. Cell, 89, 17-24.
14. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. and Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 502-512.
15. Chinnaiyan, A.M. et al. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR0-1 and CD95. Science, 274, 990-992.
16. Cohen, J. (1988) Cytokines as mediators of graft-versus-host disease. Bone Marrow Transplant., 3, 193-197.
17. Cosman, D. (1994) A family of ligands for the TNF receptor superfamily. Stem Cells, 12, 440-455.
18. Dhein, J., Walczak, H., Bäumler, C. Debatin, K.-M. and Krammer, P.H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature, 373, 438-441.
19. Fanslow, W.C., Srinivasan, S., Paxton, R., Gibson, M.G., Spriggs, M.K. and Armitage, R.J. (1994) Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol., 6, 267-278.
20. Fiers, W. (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett., 285, 199-212.
21. French, L.E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C. and Tschopp, J. (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol., 133, 335-343.
22. Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W.P., Krammer, P.H. and Runkel, L. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med., 182, 1223-1230.
23. Griffith, T.S., Brunner, T., Fletcher, S., Green, D.R. and Ferguson, T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270, 1189-1192.
24. Gubler, U. and Hoffman, B.J. (1983) A simple and very efficient method for generating cDNA libraries. Gene, 25, 263-269.
25. Hahne, M. et al. (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science, 274, 1363-1366.
26. Hsu, H., Xiong, J. and Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell, 81, 495-504.
27. Hunt, D.F., Yates, J.R.I., Shabanowitz, J., Winston, S. and Hauer, C.R. (1986) Protein sequencing by tandem mass spectrometry. Proc. Natl Acad. Sci. USA, 83, 6233-6237.
28. Ju, S.-T., Panka, D.J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D.H., Stanger, B.Z. and Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373, 444-448.
29. Kägi, D., Vignaux, F., Lederman, B., Burkin, K., Depretere, V., Nagata, S., Hengartner, H. and Golstein, P. (1994) Fas and perform pathway as major mechanisms of T-cell mediated cytotoxicity. Science, 265, 528-530.
30. Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.H. and Peter, M.E. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J., 14, 5579-5588.
31. Kitson, J., Raven, T., Jiang, Y.P., Goeddel, D.V., Giles, K.M., Pun, K.T., Grinham, C.J., Brown, R. and Farrow, S.N. (1996) A death-domain-containing receptor that mediates apoptosis. Nature, 384, 372-375.
32. Kondo, T., Takashi, S., Fukuyama, H., Adachi, M. and Nagata, S. (1997) Essential roles of the Fas ligand in the development of hepatitis. Nature Med., 3, 409-413.
33. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, J. and Debatin, K.M. (1994) Regulation of apoptosis in the immune system. Curr. Opin. Immunol., 6, 279-289.
34. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994) Cytolytic T-cell-cytotoxicity is mediated through perform and Fas ligand pathways. Nature, 370, 650-653.
35. Mann, M. and Wilm, M. (1994) Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem., 66, 4390-4399.
36. March, C.J. et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature, 315, 641-647.
37. Mariani, S.M., Matiba, B., Armandola, E.A. and Krammer, P.H. (1997) Interleukin 1beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol., 137, 221-229.
38. Marsters, S.A., Pitti, R.M., Donahue, C.J., Ruppert, S., Bauer, K.D. and Ashkenazi, A. (1996a) Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr. Biol., 6, 750-752.
39. Marsters, S.A., Sheridan, J.P., Donahue, C.J., Pitti, R.M., Gray, C.L., Goodard, A.D., Bauer, K.D. and Ashkenazi, A. (1996b) APO-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol., 6, 1669-1676.
40. Mohler, K.M., Torrance, D.S., Smith, C.A., Goodwin, R.G., Stremler, K.E., Fung, V.P., Madani, H. and Widmer, M.B. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol., 151, 1548-1561.
41. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
42. Muzio, M. et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817-827.
43. Nagata, S. (1997) Apoptosis by death factor. Cell, 88, 355-365.
44. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139, 271-279.
45. Pan, G., O'Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J. and Dixit, V.M. (1997) The receptor for the cytotoxic ligand TRAIL. Science, 276, 111-113.
46. Peter, M.E., Hellbardt, S., Schwartz-Albiez, R., Westendorp, O., Walczak, H., Moldenhauer, G., Grell, M. and Krammer, P.H. (1995) Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ., 2, 163-171.
47. Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A. and Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem., 271, 12687-12690.
48. Revel, M. and Schattner, A. (1987) Interferons: cytokines in autoimmunity. Ciba Found. Symp., 129, 223-233.
49. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
50. Shevchenko, A., Wilm, M., Vorm, O. and Mann, M. (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem., 68, 850-858.
51. Simonet, W.S. et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89, 309-319.
52. Smith, C.A. et al. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell, 73, 1349-1360.
53. Smith, C.A., Farrah, T. and Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76, 959-962.
54. Sprent, J., Kishimoto, H., Cai, Z., Surh, C.D., Brunmark, A., Jackson, M.R. and Peterson, P.A. (1996) The thymus and T cell death. Adv. Exp. Med. Biol., 406, 191-198.
55. Strand, S. et al. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/ Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med., 2, 1361-1366.
56. Sytwu, H.K., Liblau, R.S. and McDevitt, H.O. (1996) The roles of Fas/ APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity, 5, 17-30.
57. Takahashi, T., Tanaka, M., Abe, T., Suda, T. and Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol., 6, 1567-1574.
58. Takle, L.A. and Knowles, M.A. (1996) Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene, 12, 1083-1087.
59. Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Konishi, M., Oshimura, M. and Miyaki, M. (1996) Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8p12-pter. Oncogene, 12, 405-410.
60. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
61. Wiley, S.R. et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-682.
62. Wilm, M. and Mann, M. (1996) Analytical properties of the nanoelectrospray ion source. Anal. Chem., 68, 1-8.
63. Wyllie, A.H., Kerr, J.F. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
64. Zheng, L.X., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H. and Lenardo, M.J. (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature, 377, 348-351.